等待開盤 01-28 09:30:00 美东时间
-0.455
-1.17%
Five Star (NASDAQ:FSBC) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.76 by 8.92 percent. This is a 31.75 percent increase over earnings of $0.63 per share from the same
01-27 16:05
Five Star Bancorp's Q4 net income rises 32% Overview Banking firm's Q4 net income rose to $17.6 mln, up from $13.3 mln last year Net interest income for Q4 increased, driven by loan growth and yield improvement Company announced increased dividend for the quarter Outlook Five Star Bancorp plans to m
01-27 07:42
BRIEF-Five Star Bancorp Q4 EPS USD 0.83 Jan 26 (Reuters) - Five Star Bancorp Q4 net income USD 17.643 million. Q4 net interest margin 3.66% Q4 net interest income USD 42.1 million
01-27 07:30
Five Star Bancorp FY net income rises 35% to USD 61.6 million Five Star Bancorp reported net income of USD 17.6 million for the fourth quarter (Q4) ended 31 December 2025. Basic and diluted earnings per common share for Q4 2025 were USD 2.90. For the full year (FY) 2025, net income was USD 61.6 mill
01-27 07:30
Companies Reporting Before The Bell • Ryanair Hldgs (NASDAQ:RYAAY) is likely to...
01-26 19:11
Five Star Bancorp (FSBC) declares $0.25/share quarterly dividend, 25% increase from prior dividend of $0.20. Forward yield 2.65% Payable Feb. 9; for shareholders of record Feb. 2; ex-div Feb. 2. See F...
01-17 04:13
五点星金融公司(Five Star Bancorp)计划于2026年1月26日股市收盘后公布截至2025年12月31日的季度及年度财务报告。投资者会议将于1月27日上午10点(PT)/下午1点(ET)举行,可通过公司官网(https://investors.fivestarbank.com/news-events/events)预先注册并参与直播,直播存档90天。如需联系,请访问公司网站获取更多信息。 总结:五点星金融公司预计1月26日发布2025财年第四季度及全年财务报告,并于1月27日举行网络直播会议。投资者可通过公司官网预先注册并参与,直播将存档90天。
01-13 17:30
James Beckwith, President and CEO of Five Star Bancorp, has been named Sacramentan of the Year by the Sacramento Metropolitan Chamber of Commerce for his decades of leadership, community investment, and regional advancement. Under his leadership, Five Star Bank has earned numerous awards and expanded into key markets like San Francisco and Walnut Creek. Beckwill also actively supports non-profits, schools, and economic development in the Greater ...
2025-11-20 17:30
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
2025-10-31 10:25
今日重点评级关注:HC Wainwright & Co.:维持Unicycive Therapeutics"买入"评级,目标价从9美元升至22美元;花旗:维持Arcus Biosciences"买入"评级,目标价从54美元升至56美元
2025-10-30 14:22